Carregant...
Delivering on the promise: PARP inhibition as targeted anti-cancer therapy
PURPOSE OF THE REVIEW: Authors present the rationale, clinical development, and current status of Poly (adenosine diphospohate [ADP]) ribose polymerase (PARP) inhibitors (PARPi) as anticancer agents. RECENT FINDINGS: The recent approval of olaparib in heavily pre-treated patients with advanced ovari...
Guardat en:
| Publicat a: | Curr Opin Oncol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4636335/ https://ncbi.nlm.nih.gov/pubmed/26447876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0000000000000238 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|